Syntec Optics (OPTX) Competitors $1.60 +0.02 (+1.27%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.58 -0.02 (-1.00%) As of 02/21/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends OPTX vs. NAUT, KEQU, FEIM, RPID, SEER, AKYA, INTT, MASS, OWLT, and PREShould you be buying Syntec Optics stock or one of its competitors? The main competitors of Syntec Optics include Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), Rapid Micro Biosystems (RPID), Seer (SEER), Akoya Biosciences (AKYA), inTEST (INTT), 908 Devices (MASS), Owlet (OWLT), and Prenetics Global (PRE). These companies are all part of the "measuring and control equipment" industry. Syntec Optics vs. Nautilus Biotechnology Kewaunee Scientific Frequency Electronics Rapid Micro Biosystems Seer Akoya Biosciences inTEST 908 Devices Owlet Prenetics Global Nautilus Biotechnology (NASDAQ:NAUT) and Syntec Optics (NASDAQ:OPTX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability. Is NAUT or OPTX more profitable? Syntec Optics has a net margin of 0.21% compared to Nautilus Biotechnology's net margin of 0.00%. Syntec Optics' return on equity of 0.50% beat Nautilus Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Nautilus BiotechnologyN/A -28.85% -24.93% Syntec Optics 0.21%0.50%0.23% Do analysts recommend NAUT or OPTX? Nautilus Biotechnology currently has a consensus price target of $3.58, suggesting a potential upside of 132.68%. Given Nautilus Biotechnology's stronger consensus rating and higher possible upside, analysts clearly believe Nautilus Biotechnology is more favorable than Syntec Optics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nautilus Biotechnology 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Syntec Optics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor NAUT or OPTX? In the previous week, Nautilus Biotechnology had 2 more articles in the media than Syntec Optics. MarketBeat recorded 2 mentions for Nautilus Biotechnology and 0 mentions for Syntec Optics. Nautilus Biotechnology's average media sentiment score of 0.00 equaled Syntec Optics'average media sentiment score. Company Overall Sentiment Nautilus Biotechnology Neutral Syntec Optics Neutral Does the MarketBeat Community believe in NAUT or OPTX? Nautilus Biotechnology received 4 more outperform votes than Syntec Optics when rated by MarketBeat users. CompanyUnderperformOutperformNautilus BiotechnologyOutperform Votes419.05%Underperform Votes1780.95% Syntec OpticsN/AN/A Which has more volatility & risk, NAUT or OPTX? Nautilus Biotechnology has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Syntec Optics has a beta of -1.48, indicating that its share price is 248% less volatile than the S&P 500. Which has stronger earnings and valuation, NAUT or OPTX? Syntec Optics has higher revenue and earnings than Nautilus Biotechnology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNautilus BiotechnologyN/AN/A-$63.67M-$0.56-2.75Syntec Optics$29.44M1.99$1.98MN/AN/A Do institutionals and insiders believe in NAUT or OPTX? 50.7% of Nautilus Biotechnology shares are owned by institutional investors. 40.5% of Nautilus Biotechnology shares are owned by company insiders. Comparatively, 0.2% of Syntec Optics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryNautilus Biotechnology beats Syntec Optics on 8 of the 13 factors compared between the two stocks. Get Syntec Optics News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPTX vs. The Competition Export to ExcelMetricSyntec OpticsOptical instruments & lenses IndustryBusiness SectorNASDAQ ExchangeMarket Cap$58.70M$14.05B$7.81B$8.98BDividend YieldN/A1.24%2.20%3.85%P/E RatioN/A34.8533.8518.82Price / Sales1.998.6467.5580.82Price / Cash2.1020.4832.3137.47Price / Book0.756.775.424.64Net Income$1.98M$324.03M$187.27M$245.69M7 Day Performance-8.57%-4.03%-2.92%-2.63%1 Month Performance-10.11%-10.92%-2.68%-2.37%1 Year Performance-69.52%4.96%18.85%13.65% Syntec Optics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPTXSyntec Optics0.4603 of 5 stars$1.60+1.3%N/A-69.5%$57.97M$29.39M0.003Gap UpNAUTNautilus Biotechnology2.3977 of 5 stars$1.71-0.6%$3.58+109.6%-44.4%$214.71MN/A-3.05130Upcoming EarningsNews CoverageKEQUKewaunee Scientific1.2863 of 5 stars$66.07-5.2%N/A+94.5%$189.75M$199.64M10.471,006FEIMFrequency Electronics2.5403 of 5 stars$17.47+1.3%N/A+45.4%$167.89M$55.27M21.31200Positive NewsRPIDRapid Micro Biosystems2.5385 of 5 stars$3.48-2.5%$8.00+129.9%+241.5%$149.76M$26.17M-3.11200SEERSeer2.3496 of 5 stars$2.31flat$3.00+29.9%+43.9%$136.22M$16.66M-1.78160High Trading VolumeAKYAAkoya Biosciences2.8083 of 5 stars$2.31+2.7%$5.43+135.0%-61.0%$114.51M$86.82M-1.9690Positive NewsINTTinTEST1.8999 of 5 stars$8.25-0.2%$16.00+93.9%-26.7%$102.14M$123.30M35.87320News CoverageMASS908 Devices2.9512 of 5 stars$2.78+8.6%$5.33+91.8%-63.6%$96.80M$50.23M-1.5760Analyst ForecastGap UpOWLTOwlet3.2804 of 5 stars$4.88+3.2%N/A+14.9%$78.28M$54M-2.04106Analyst ForecastNews CoveragePREPrenetics Global3.0036 of 5 stars$5.44-1.2%$9.00+65.6%+5.1%$66.33M$25.56M-1.361 Related Companies and Tools Related Companies NAUT Alternatives KEQU Alternatives FEIM Alternatives RPID Alternatives SEER Alternatives AKYA Alternatives INTT Alternatives MASS Alternatives OWLT Alternatives PRE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OPTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syntec Optics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syntec Optics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPTX Stock Alerts